Clinical Trial

Study SOLACE SEPSIS

Study acronym: MJIP1_0
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-07; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2025-04-08
Trial Details
NCT Number NCT06634069
Lead Sponsor University Hospital Pilsen
Conditions Septic Shock, Intracranial Hypertension
Enrollment 40 participants
Start Date 2024-11-24
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14